Clinical Trials on Advanced Solid Tumors (Phase 1) in Italy
Total 275 results
-
BeiGeneRecruitingLocally Advanced or Metastatic Solid Tumors for Phase 1,Dose Escalation and Phase 2 Safety Lead-in, HNSCC, NSCLC and RCC Participants for Phase 2Australia, Spain, France, Italy, Korea, Republic of, Poland
-
PfizerTerminatedLocally Advanced or Metastatic Solid Tumors | Genes, BRCA 1United States, Belgium, Spain, Denmark, Japan, France, Italy, Netherlands, United Kingdom
-
Southern Europe New Drug OrganizationBayer; NovartisSuspendedAdvanced Solid TumorsItaly
-
AGC Biologics S.p.A.Completed
-
Southern Europe New Drug OrganizationCelgene CorporationUnknown
-
Southern Europe New Drug OrganizationNovartis; Schering-PloughUnknownAdvanced Solid TumorsItaly, Switzerland
-
Taiho Oncology, Inc.CompletedAdvanced Solid TumorsFrance, Belgium, Italy, Switzerland
-
Incyte CorporationRecruitingA Study to Evaluate the Safety of INCA33890 in Participants With Advanced or Metastatic Solid TumorsAdvanced Solid Tumors | Solid Tumors | Metastatic Solid TumorsUnited States, Spain, United Kingdom, France, Italy, Denmark, Switzerland
-
Philogen S.p.A.RecruitingAdvanced Solid Tumor | Metastatic Solid TumorItaly, Germany, Switzerland
-
Taiho Oncology, Inc.TerminatedAdvanced Solid TumorsItaly, Spain, United States, Netherlands, United Kingdom
-
PfizerCompletedA First In Patient, Study Of Investigational Drug PF-03446962 In Patients With Advanced Solid TumorsAdvanced Solid TumorsUnited States, Korea, Republic of, Italy
-
Epizyme, Inc.CompletedB-cell Lymphomas (Phase 1) | Advanced Solid Tumors (Phase 1) | Diffuse Large B-cell Lymphoma (Phase 2) | Follicular Lymphoma (Phase 2) | Transformed Follicular Lymphoma | Primary Mediastinal Large B-Cell LymphomaAustralia, Canada, France, Germany, Italy, Poland, Taiwan, Ukraine, United Kingdom, United States
-
Taiho Oncology, Inc.CompletedAdvanced Solid TumorsUnited States, United Kingdom, Italy
-
Vall d'Hebron Institute of OncologyTaisho Pharmaceutical Co., Ltd.; Roche Pharma AG; Iqvia Pty Ltd; Janssen, LPRecruitingAdvanced Solid TumorSpain, France, Germany, Netherlands, Sweden, United Kingdom, Italy
-
Istituto Scientifico Romagnolo per lo Studio e...RecruitingProstate-specific Membrane Antigen | mCRPC or Advanced/Metastatic Solid TumorsItaly
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedAdvanced Solid TumorsSpain, United States, Netherlands, Hungary, Italy, France, Belgium
-
Novartis PharmaceuticalsRecruitingAdvanced Solid TumorsSwitzerland, Italy, Spain, Germany, Hong Kong, Hungary, Belgium, Korea, Republic of, China, Czechia, Canada, United States, France, Poland, Thailand, Netherlands, Taiwan
-
Novartis PharmaceuticalsCompletedcMET-dysregulated Advanced Solid TumorsUnited States, Italy, Spain, United Kingdom, Greece, Belgium, Austria, Czechia
-
MedImmune LLCCompletedAdvanced Solid TumorsUnited States, Germany, Italy, United Kingdom, Belgium, Canada, Korea, Republic of, Taiwan, France
-
PharmaMarCompletedAdvanced Solid TumorsSpain, United States, Belgium, France, Italy, Switzerland, Germany, Sweden, United Kingdom
-
ImmunoGen, Inc.MacroGenicsCompletedAdvanced Solid TumorUnited States, Italy, Spain
-
MedImmune LLCActive, not recruitingAdvanced Solid TumorsUnited States, Spain, Belgium, Italy, Korea, Republic of, Canada, Australia, Hungary, United Kingdom, France, New Zealand
-
Novartis PharmaceuticalsCompletedcMET-dysregulated Advanced Solid TumorsUnited States, Spain, Italy, Bulgaria, United Kingdom, France, Denmark
-
Hoffmann-La RocheCompletedAdvanced/Metastatic Solid TumorsUnited States, Belgium, Denmark, Spain, Netherlands, Canada, Italy
-
Bristol-Myers SquibbRecruitingAdvanced Solid TumorsCanada, United States, Argentina, France, Spain, Italy, Australia, Mexico, Chile
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLCCompletedAdvanced Solid TumorsUnited States, Korea, Republic of, Taiwan, Portugal, Spain, United Kingdom, Italy, Canada, Japan
-
Federation of Italian Cooperative Oncology GroupsBristol-Myers Squibb; Eli Lilly and Company; Bayer; Novartis; Roche Pharma AG; Takeda; AstraZene... and other collaboratorsRecruiting
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors | Metastatic Solid TumorsFrance, Netherlands, Spain, Canada, Singapore, Germany, Korea, Republic of, Australia, Belgium, Switzerland, Italy, United States
-
MedImmune LLCActive, not recruitingSelected Advanced Solid TumorsItaly, Spain, United States, France, Korea, Republic of, Taiwan, Australia, Netherlands, Portugal
-
Novartis PharmaceuticalsTerminatedAdvanced Solid TumorsSpain, Japan, Taiwan, Italy, Switzerland, Israel, United States, Singapore
-
Bristol-Myers SquibbActive, not recruitingAdvanced or Metastatic Solid TumorsUnited States, Spain, Italy, Canada, Germany, United Kingdom, Denmark, Finland
-
AbbVieActive, not recruitingAdvanced Solid Tumors CancerUnited States, Belgium, France, Italy, Japan, Korea, Republic of, Netherlands, Taiwan, Finland
-
Incyte CorporationCompletedLocally Advanced Solid Tumors | Metastatic Solid TumorsFrance, Spain, United States, China, United Kingdom, Lithuania, Germany, Ukraine, Finland, Italy, Belgium, Australia, Bulgaria, Latvia, New Zealand, Poland
-
Janssen Research & Development, LLCActive, not recruitingAdvanced Solid TumorFrance, United States, Japan, Belgium, United Kingdom, Germany, Korea, Republic of, Taiwan, China, Poland, Italy, Spain, Australia, Brazil, Argentina
-
Phost'In TherapeuticsRecruitingGlioblastoma Multiforme | Metastatic Cancer | Advanced Solid Tumor | Malignant TumorItaly, France
-
Philogen S.p.A.Syneos HealthCompleted
-
Incyte CorporationMirati Therapeutics Inc.RecruitingAdvanced Solid TumorsUnited States, Italy, Spain, United Kingdom
-
BayerActive, not recruitingAdvanced Solid TumorsUnited States, Singapore, Italy, United Kingdom
-
Merck Sharp & Dohme LLCCompletedAdvanced Solid TumorsUnited States, Australia, Canada, Chile, China, France, Greece, Israel, Italy, Japan, Korea, Republic of, New Zealand, Poland, South Africa, Spain, Sweden
-
Novartis PharmaceuticalsCompletedAdvanced Solid Tumors With Alterations of FGFR1, 2 and or 3 | Squamous Lung Cancer With FGFR1 Amplification | Bladder Cancer With FGFR3 Mutation or Fusion | Advanced Solid Tumors With FGFR1 Amplication | Advanced Solid Tumors With FGFR2 Amplication | Advanced Solid Tumors With FGFR3 MutationFrance, Spain, Taiwan, Germany, Netherlands, Singapore, United States, Australia, Korea, Republic of, Thailand, Israel, Italy, Turkey, Austria
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruiting
-
PfizerTerminatedEarly Breast Cancer (Phase 2) | Advanced Breast Cancer (Phase 1b)Spain, Sweden, Italy, Belgium
-
AGC Biologics S.p.A.Completed
-
AGC Biologics S.p.A.Completed
-
Nuvalent Inc.RecruitingMetastatic Solid Tumor | Locally Advanced Solid TumorUnited States, Australia, Taiwan, Spain, United Kingdom, Korea, Republic of, Italy, France, Singapore, Canada, Netherlands
-
Novartis PharmaceuticalsRecruitingAdvanced Solid Tumors Which Are cMET-dependentGermany, Korea, Republic of, Belgium, Italy, Singapore, United States, Denmark, Spain, France, Canada
-
Array BioPharmaCompletedAML | Advanced and Selected Solid Tumors | High Risk and Very High Risk MDSUnited States, Australia, Italy, Spain, France, Switzerland, United Kingdom
-
Istituto Clinico HumanitasCompleted
-
Glycotope GmbHCompleted
-
Fondazione MichelangeloCompleted